Evidence map›Paper›PMID 30013377›Full record

ArticleDiabetes, metabolic syndrome and obesity : targets and therapy2018

Effects of glucosyl-hesperidin and physical training on body weight, plasma lipids, oxidative status and vascular reactivity of rats fed with high-fat diet.

Tiago Tomazini Gonçalves, Carolina M Lazaro, Fernanda G De Mateo, Marcela Cb Campos, Jackeline Gb Mezencio, Mario A Claudino, Patrícia de O Carvalho, R Clinton Webb, Fernanda Bm Priviero

Open access · goldAbstract read
In one paragraph

Article in Diabetes, metabolic syndrome and obesity : targets and therapy, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.7field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 10 citations in OpenAlex.

  1. Trial
  2. Article
  3. Biomolecules & therapeutics · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Tiago Tomazini GonçalvesLaboratory of Multidisciplinary Research, Universidade São Francisco, Bragança Paulista, São Paulo, Brazil, fernanda.bmp@gmail.com.
Carolina M LazaroLaboratory of Multidisciplinary Research, Universidade São Francisco, Bragança Paulista, São Paulo, Brazil, fernanda.bmp@gmail.com.
Fernanda G De MateoLaboratory of Multidisciplinary Research, Universidade São Francisco, Bragança Paulista, São Paulo, Brazil, fernanda.bmp@gmail.com.
Marcela Cb CamposLaboratory of Multidisciplinary Research, Universidade São Francisco, Bragança Paulista, São Paulo, Brazil, fernanda.bmp@gmail.com.
Jackeline Gb MezencioLaboratory of Multidisciplinary Research, Universidade São Francisco, Bragança Paulista, São Paulo, Brazil, fernanda.bmp@gmail.com.
Mario A ClaudinoLaboratory of Multidisciplinary Research, Universidade São Francisco, Bragança Paulista, São Paulo, Brazil, fernanda.bmp@gmail.com.
Patrícia de O CarvalhoLaboratory of Multidisciplinary Research, Universidade São Francisco, Bragança Paulista, São Paulo, Brazil, fernanda.bmp@gmail.com.
R Clinton WebbDepartment of Physiology, Medical College of Georgia, Augusta University, Augusta, GA, USA, fernanda.bmp@gmail.com.
Fernanda Bm PrivieroLaboratory of Multidisciplinary Research, Universidade São Francisco, Bragança Paulista, São Paulo, Brazil, fernanda.bmp@gmail.com.
Universidade São Francisco · BRAugusta University · US

Funding

Toll-like receptor 9 activation by mitochondrial DNA causes vascular injury in hypertensionP01HL134604 · NHLBI · AUGUSTA UNIVERSITY · PI BRANDS, MICHAEL W. · 2017 to 2021
$9.4M
NHLBI NIH HHS P01 HL134604
6 · The paper itself

Abstract

objectiveThe aim of the study was to evaluate the effects of supplementation with glucosyl hesperidin (GH), with or without physical training, on body weight, fat depot, glucose and plasma lipids, oxidative status and vascular function of rats fed with high-fat diet (HFD).

methodsAfter weaning, male Wistar rats were fed with an HFD plus fructose for 12 weeks and started receiving oral antioxidant supplementation and/or physical training after the fourth week of diet for eight further weeks. Body weight, epididymal and retroperitoneal fat, plasma glucose and lipids, oxidative status and mesenteric artery reactivity were evaluated.

resultsRats fed with HFD presented higher body weight gain and fat accumulation compared to control rats, while GH supplementation did not influence these parameters. Physical training reduced the body weight gain and fat accumulation and modulated the oxidative status by increasing superoxide dismutase activity and total antioxidant capacity and reducing lipid peroxidation. GH alone decreased lipid peroxidation. However, when given to exercised rats, it impaired the response elicited by physical training. HFD caused endothelial dysfunction, and neither GH nor physical exercise prevented it. Potency of sodium nitroprusside was increased in exercised animals but not in GH-supplemented rats.

conclusionPhysical exercise partially decreased the body fat accumulation, decreased plasma levels of glucose and lipids and improved general oxidative status and endothelium-independent relaxation in mesenteric arteries of rats fed with HFD. GH exhibited benefits only in the oxidative status. However, GH given in association with physical exercise did not cause further changes in addition to those promoted by physical exercise. On the contrary, in exercised animals, GH prevented those changes elicited by physical training in plasma glucose and lipids, oxidative status and endothelium-independent relaxation.

Indexed as

antioxidantsflavonoidshigh-fat dietobesityoxidative stressphysical activityphysical exercisereactive oxygen speciessupplementation

Identifiers

PMID30013377
PMCPMC6037267
OpenAlexW2810611484

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.